We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.21B
AUM Growth
-$350M
Cap. Flow
-$505M
Cap. Flow %
-12.01%
Top 10 Hldgs %
13.44%
Holding
2,287
New
535
Increased
420
Reduced
369
Closed
606

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$29.4M
2
AMZN icon
Amazon
AMZN
+$17.1M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
MSFT icon
Microsoft
MSFT
+$13.6M
5
GFF icon
Griffon
GFF
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.49%
2 Technology 12.02%
3 Consumer Discretionary 5.9%
4 Industrials 5.35%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVSA
1626
Covista Inc
CVSA
$4.39B
-8,769
Closed -$301K
ATMU icon
1627
Atmus Filtration Technologies
ATMU
$4.42B
-42,698
Closed -$938K
OPTU
1628
CALL
Optimum Communications Inc
OPTU
$307M
-50,000
Closed -$151K
AUPH icon
1629
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
-13,000
Closed -$126K
AVPT icon
1630
AvePoint
AVPT
$2.84B
-101,330
Closed -$584K
AVTR icon
1631
Avantor
AVTR
$9.04B
-13,097
Closed -$269K
AX icon
1632
Axos Financial
AX
$5.89B
-11,577
Closed -$457K
DCH
1633
Dauch Corp
DCH
$1.42B
-33,883
Closed -$280K
AXSM icon
1634
CALL
Axsome Therapeutics
AXSM
$11B
-36,900
Closed -$2.65M
AXSM icon
1635
PUT
Axsome Therapeutics
AXSM
$11B
-36,900
Closed -$2.65M
AZN icon
1636
CALL
AstraZeneca
AZN
$250B
-172,650
Closed -$24.7M
AZN icon
1637
AstraZeneca
AZN
$250B
-34,189
Closed -$4.67M
BA icon
1638
CALL
Boeing
BA
$190B
-20,000
Closed -$4.22M
BABA icon
1639
CALL
Alibaba
BABA
$308B
-56,000
Closed -$4.67M
BAERW icon
1640
Bridger Aerospace Warrant
BAERW
$10.9M
-19,345
Closed -$108K
BB icon
1641
BlackBerry
BB
$5.12B
-293,938
Closed -$1.63M
BBIO icon
1642
PUT
BridgeBio Pharma
BBIO
$16.1B
-30,000
Closed -$516K
BC icon
1643
Brunswick
BC
$5.43B
-3,019
Closed -$262K
BCLI
1644
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-1,273
Closed -$39.3K
BCYC
1645
Bicycle Therapeutics
BCYC
$277M
-42,133
Closed -$1.08M
BE icon
1646
CALL
Bloom Energy
BE
$69B
-13,800
Closed -$226K
BEEM icon
1647
Beam Global
BEEM
$24.9M
-17,619
Closed -$182K
BG icon
1648
CALL
Bunge Global
BG
$20.5B
-2,200
Closed -$208K
BHC icon
1649
Bausch Health
BHC
$2.35B
-442,854
Closed -$3.54M
BHVN icon
1650
CALL
Biohaven
BHVN
$2.05B
-45,100
Closed -$1.08M

Similar funds

Boothbay Fund Management's Q3 2023 Portfolio in Review

As of Q3 2023, Boothbay Fund Management held 2,287 positions worth $4.21B, down 7.7% from $4.56B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boothbay Fund Management withdrew a net $505M in Q3 2023, closing 606 positions and reducing 369 holdings. Its most notable exit was Mastercard, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in VMware, Inc worth $58.4M.

  • Boothbay Fund Management's largest Q3 2023 buy was VMware, Inc: 350,588 shares worth $58.4M.
  • Boothbay Fund Management added most to Zimmer Biomet in Q3 2023, an estimated $34.2M increase.
  • Boothbay Fund Management's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $29.4M.
  • Boothbay Fund Management fully exited Mastercard in Q3 2023, selling an estimated $13.1M.
  • Boothbay Fund Management's ten largest holdings make up 13% of its $4.21B portfolio in Q3 2023.
  • Boothbay Fund Management opened 535 new positions and closed 606 in Q3 2023.
  • Boothbay Fund Management's portfolio value fell 7.7% quarter-over-quarter to $4.21B.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.